Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing patients on interferon therapy

R Esteban1

  • 1Liver Unit, Hospital Valle De Hebron, Barcelona, Spain.

Digestive Diseases and Sciences
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Interferon (IFN) is standard for chronic hepatitis C, requiring careful diagnosis and monitoring. New techniques like polymerase chain reaction (PCR) show promise for evaluating treatment response and relapse risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Downed woody debris carbon emissions in a European temperate virgin forest as driven by species, decay classes, diameter and microclimate.

The Science of the total environment·2023
Same author

Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2020
Same author

Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Cost-effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis C: Treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosis.

Journal of viral hepatitis·2017
Same author

High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtyping.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort.

Journal of viral hepatitis·2016
Same journal

Rapid Gastric Emptying: Insights from a Large Cohort Study on a Controversial Disorder.

Digestive diseases and sciences·2026
Same journal

Readability, Quality, Understandability, and Actionability of ChatGPT Generated GI Patient Education Versus AGA Patient Center.

Digestive diseases and sciences·2026
Same journal

Distinctive Endoscopic Ultrasound Features of Pancreatic Adenosquamous Carcinoma: A Propensity Score-Matched Analysis.

Digestive diseases and sciences·2026
Same journal

FIGThe Efficacy and Safety of Clip-Assisted Endoscopic Cyanoacrylate Injection for Gastric Varices: A Systematic Review and Meta-Analysis.

Digestive diseases and sciences·2026
Same journal

Gastroscopic Removal of a Duodenal Foreign Body in a 94-Year-Old Patient.

Digestive diseases and sciences·2026
Same journal

Colorectal Cancer Outcomes Among Disaggregated Asian Subgroups: a 2006-2020 SEER Analysis.

Digestive diseases and sciences·2026
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Interferon (IFN) is the standard therapy for chronic hepatitis C (HCV).
  • Accurate diagnosis and monitoring are crucial for effective IFN therapy.
  • Liver biopsy is the gold standard for assessing HCV disease severity and cirrhosis.

Purpose of the Study:

  • To review diagnostic and monitoring techniques for chronic hepatitis C (HCV) during Interferon (IFN) therapy.
  • To highlight the limitations of current diagnostic methods and the potential of newer technologies.
  • To discuss adverse effects of IFN therapy and contraindications.

Main Methods:

  • Review of existing literature on Interferon (IFN) therapy for chronic hepatitis C (HCV).
  • Discussion of diagnostic tools including liver biopsy, serological tests (ELISA), and emerging techniques like PCR.

Related Experiment Videos

  • Analysis of adverse effects and contraindications for IFN treatment.

    • Main Results:

    • ALT normalization is insufficient for assessing short-term response to IFN.
    • Adverse effects of IFN are manageable, but autoimmune hepatitis (AIH) and psychiatric conditions are contraindications.
    • Polymerase chain reaction (PCR) techniques show promise for monitoring treatment response and relapse risk in HCV patients.

    Conclusions:

    • Distinguishing autoimmune hepatitis (AIH) from HCV infection is critical.
    • Advanced diagnostic and monitoring techniques, particularly PCR, are needed to optimize IFN therapy for chronic hepatitis C.
    • Careful patient selection and monitoring are essential for managing IFN therapy effectively.